Westlake Genetech

Westlake Genetech is a private Chinese biotech company developing AI-powered gene therapy technologies and product candidates. Originating from Westlake University and Westlake Laboratory, the company combines high-throughput biological data generation with deep learning to support gene editing, vector engineering, and target discovery. Its disclosed platform suite includes AIdit-CAPSID for AAV capsid engineering, AIdit-CRISPR/AIdit-EDIT for gene editing design and prediction, and AIdit-TARGET for discovery workflows. The company describes itself as pursuing a dual strategy of platform development and internal pipeline creation, including gene editing therapies and in vivo engineered cell therapy concepts such as in vivo CAR-T. It also states that it has built GMP capabilities to support clinical translation of gene-modified cell therapy products.